24,644% Returns, 9:5 Bonus, 1:2 & 1:5 Splits: Pharma Stock Turns Rs 50K To Rs 1.23 Cr In 6 Years; Do You Own?

Remedium Lifecare is a long-term wealth-creating stock in the pharma basket. The stock trading below Rs 120, has given a massive 24,644.44% return in a six-year span. A Rs 50,000 investment, six years ago, is now worth around Rs 1.23 crore. Not just strong returns, Remedium has rewarded investors with two stock splits and 9 bonus shares during this period.

Remedium Lifecare Share Price:

After rising by 10.4% in a two-day winning streak, Remedium shares halted to turn bearish and witnessed profit booking on April 19. The stock price ended at Rs 111.35 apiece, down by 2.75% on BSE with a market cap of Rs 1,122.41 crore. But its weekly gains stood positive with a marginal upside.

The stock's 52-week high and low is at Rs 179.66 apiece and Rs 45.03 apiece respectively.

Remedium Lifecare Long-Term Gains:

YTD, Remedium shares have zoomed by 11.6% on BSE so far. But in a year, the stock becomes a multi-bagger with gains of more than 135%. It's not enough! Remedium gives breathtaking 20,520% returns to investors who have stayed invested for about 5 years.

But in 6 years, the stock has skyrocketed by a whopping 24,644.44 apiece. 6 years ago, in May 2018, Remedium shares were at Rs 0.45 apiece.

And let's suppose, anyone pumped in Rs 50,000 for Remedium shares on May 25, 2018, their corpus is now worth Rs 1,23,72,220 or Rs 1.23 crore, giving 24,644.44% returns.

Remedium Lifecare Earnings:

Remedium will announce its Q4 results anytime soon as the last quarterly earnings for FY24 have begun. But so far FY24 has been robust growth for Remedium.

9MFY24 revenue is at Rs 2,633.21 crore, compared to Rs 434.25 crore in 9MFY23. Q3FY24 revenue stood at Rs 1,834.17 crore, versus Rs 468.56 crore in Q2FY24 and Rs 176.47 crore in Q3FY23.

Further, 9MFY24 net profit rose by multi-fold to Rs 86.45 crore versus Rs 10.20 crore in 9MFY23. In Q3FY24, the profit was at Rs 68.77 crore versus Rs 6.52 crore in Q2FY24 and Rs 1.52 crore in Q3FY23.

Remedium has only delivered bonus issues and stock splits, but no dividend in six years so far.

Remedium Lifecare Stock Split:

In 2024, Remedium turned ex-split for a 1:5 ratio. This means that its 1 equity share with a face value of Rs 5 each has split into 5 shares having a face value of Rs 1 each.

Earlier, last year, Remedium shares turned ex-split on September 1, 2023, for a shares sub-division to the tune of 1:2. The company's stock split in the ratio of 1:2 meant that --- one existing equity share having a face value of Rs 10 each -- was sub-divided into two equity shares having a face value of Rs 5 each.

Remedium Lifecare Bonus Issue:

Remedium also rewarded investors with bonus shares in the ratio of 9:5. Accordingly, the Company issued the company nine bonus equity shares having a face value of Rs 10 each against every existing five equity shares having a face value of Rs 5 per share.

About Remedium Lifecare:

Remedium Lifecare is engaged in the trading of pharmaceutical products and various raw materials used in the pharmaceutical industry including but not limited to Aminoisophthalic Acid, Tellurium(IV) Oxide, Grignard Reagent, Iodine, Selenium Metal Powder, Trimethyl Solfoxonum Iode(TMSI). With the Remedium Lifecare entered the Bombay Stock Exchange (BSE). The stock trades under the small-cap basket.